SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-130030
Filing Date
2022-04-29
Accepted
2022-04-29 07:00:57
Documents
5
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d393239ddef14a.htm DEF 14A 385935
2 GRAPHIC g393239g00g01.jpg GRAPHIC 48378
3 GRAPHIC g393239g00g02.jpg GRAPHIC 38879
4 GRAPHIC g393239g00h01.jpg GRAPHIC 160774
5 GRAPHIC g393239g00h02.jpg GRAPHIC 155019
  Complete submission text file 0001193125-22-130030.txt   930960
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39856 | Film No.: 22870050
SIC: 2836 Biological Products, (No Diagnostic Substances)